Updates

March 4, 2021August 24, 2022
Shouting From My Laptop: Using My Voice in the IBD and Rare Disease Communities

When I returned to teaching full time after my liver transplant, I quickly discovered that the job caused me more frustration than joy. Life is ... Read more
February 25, 2021February 23, 2021
Surviving Texas’ ‘SNOVID-21’ With Crohn’s and Other Medical Needs

After the toilet paper and hand sanitizer hoarding of 2020, I thought I was equipped for anything. By luck and God’s grace, I survived the ... Read more
February 22, 2021February 22, 2021
Yuflyma, Biosimilar to Humira, Approved in EU for Chronic Inflammatory Diseases

The European Commission (EC) has granted marketing authorization to Celltrion Healthcare‘s Yuflyma (CT-P17), a biosimilar to Humira (adalimumab). The marketing authorization includes all indications for ... Read more
February 18, 2021February 16, 2021
Venturing Back Into the COVID-19 World After a Year of Self-quarantine

After my second dose of the Moderna COVID-19 vaccine last Friday, I expected days of flu-like symptoms. Luckily, I only had a low-grade fever the ... Read more
February 11, 2021February 9, 2021
How Learning to Love Myself Helped Me Fight Crohn’s

Valentine’s Day is in a few days. I told my husband, Patrick, that I wanted to spend the entire day in bed. I burst his ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

May 9, 2018May 9, 2018

Atlantic Healthcare Completes Phase 3 Trial Enrollment for Alicaforsen as Pouchitis Treatment

News

Atlantic Healthcare has completed enrollment for a Phase 3 trial evaluating the safety and efficacy of alicaforsen in patients with pouchitis, a frequent complication after surgery to treat different forms of inflammatory bowel disease (IBD). IBD patients have increased production ... Read more

Updates

Shouting From My Laptop: Using My Voice in the IBD and Rare Disease Communities

Surviving Texas’ ‘SNOVID-21’ With Crohn’s and Other Medical Needs

Yuflyma, Biosimilar to Humira, Approved in EU for Chronic Inflammatory Diseases

How Learning to Love Myself Helped Me Fight Crohn’s

Phage Therapy BX002 Shows Promise in First-in-human Trial

Sizing Myself Up: A Short Story for IBD Patients

Bacterial, Fungal Profiles Predict Infliximab Response, Study Reveals

My COVID-19 Vaccine Experience, Part 2: One Down, One to Go

Canada Approves At-home Entyvio Injection for Crohn’s

My COVID-19 Vaccine Experience, Part 1: Expectations and Frustrations

Subscribe to our mailing list

Risankizumab for 12 Weeks Leads to Remission in Crohn’s Trials

Nurturing Hope in 2021 With Fertilizer From 2020

Clinical Benefits of ABX464 for Ulcerative Colitis Revealed in Review Study

Finding a Remedy When Remicade Stops Working

EU Reviewing Zeposia as Ulcerative Colitis Treatment for Adults

Rinvoq Found Safe, Effective for Ulcerative Colitis in Ongoing Phase 3 Trial

Abivax Completes Enrollment in ABX464 Trial for Ulcerative Colitis

Chicken Soup for the Soul and IBD Symptoms

Takeda Partners With Universities on Research Into GI and Liver Disorders

Crohn’s and Colitis Awareness Week From a Minority’s Perspective

Strain of Mouth Bacteria Linked to Severe Ulcerative Colitis, Study Reports

Behind the Stall: Fear and Anxiety in Public Restrooms

IBD Charitable Foundation Announces 2020 Sherman Prize Winners

Finding My Flock: My Involvement With the IBD Community

Rare Microscopic Colitis in IBD Associated With More Active Inflammation, Study Reports

Overcoming Fecal Calprotectin Test Anxiety

Healthy Gut Microbes Maintain Social Distance From Immune System, Study Finds

Vote Like Your Life Depends on It

Zeposia Effective in Keeping Ulcerative Colitis in Remission, Phase 3 Study Shows

Heads or Tails: GI Psychology and IBD

Wearable Sweat Sensor Could Help Monitor IBD Flares, Study Finds

In the Pit of My Stomach: Depression and Anxiety With IBD

It’s Complicated: How a Roux-en-Y Affected My Routine ERCP

Compound from Blueberries Has Potential for Treating IBD, Study Suggests

I Got 99 IBD Problems, but Prostate Cancer Ain’t One

ABX464 Effective at Keeping UC Patients in Remission Over Time, Data Show

Atlantic Healthcare Completes Phase 3 Trial Enrollment for Alicaforsen as Pouchitis Treatment

Shouting From My Laptop: Using My Voice in the IBD and Rare Disease Communities

Surviving Texas’ ‘SNOVID-21’ With Crohn’s and Other Medical Needs

Yuflyma, Biosimilar to Humira, Approved in EU for Chronic Inflammatory Diseases

Venturing Back Into the COVID-19 World After a Year of Self-quarantine

How Learning to Love Myself Helped Me Fight Crohn’s

Phage Therapy BX002 Shows Promise in First-in-human Trial

Sizing Myself Up: A Short Story for IBD Patients

Bacterial, Fungal Profiles Predict Infliximab Response, Study Reveals

My COVID-19 Vaccine Experience, Part 2: One Down, One to Go

Canada Approves At-home Entyvio Injection for Crohn’s

My COVID-19 Vaccine Experience, Part 1: Expectations and Frustrations

Subscribe to our mailing list

Risankizumab for 12 Weeks Leads to Remission in Crohn’s Trials

Nurturing Hope in 2021 With Fertilizer From 2020

Clinical Benefits of ABX464 for Ulcerative Colitis Revealed in Review Study

Finding a Remedy When Remicade Stops Working

EU Reviewing Zeposia as Ulcerative Colitis Treatment for Adults

Rinvoq Found Safe, Effective for Ulcerative Colitis in Ongoing Phase 3 Trial

Abivax Completes Enrollment in ABX464 Trial for Ulcerative Colitis

Chicken Soup for the Soul and IBD Symptoms

A Week of Worry: COVID-19 Hits Home

Takeda Partners With Universities on Research Into GI and Liver Disorders

Crohn’s and Colitis Awareness Week From a Minority’s Perspective

Strain of Mouth Bacteria Linked to Severe Ulcerative Colitis, Study Reports

A Coronavirus Cornucopia: Finding Thankfulness in Chaos

Behind the Stall: Fear and Anxiety in Public Restrooms

IBD Charitable Foundation Announces 2020 Sherman Prize Winners

Finding My Flock: My Involvement With the IBD Community

Rare Microscopic Colitis in IBD Associated With More Active Inflammation, Study Reports

Overcoming Fecal Calprotectin Test Anxiety

Healthy Gut Microbes Maintain Social Distance From Immune System, Study Finds

Vote Like Your Life Depends on It

Zeposia Effective in Keeping Ulcerative Colitis in Remission, Phase 3 Study Shows

Heads or Tails: GI Psychology and IBD

Wearable Sweat Sensor Could Help Monitor IBD Flares, Study Finds

In the Pit of My Stomach: Depression and Anxiety With IBD

It’s Complicated: How a Roux-en-Y Affected My Routine ERCP

Compound from Blueberries Has Potential for Treating IBD, Study Suggests

I Got 99 IBD Problems, but Prostate Cancer Ain’t One

ABX464 Effective at Keeping UC Patients in Remission Over Time, Data Show